Krishna Ella, Ph.D., is the founder, chairman and managing director of Bharat Biotech International Limited.
After early education in agricultural sciences, Ella studied at the University of Hawaii and the University of Wisconsin-Madison. Following a brief stint as a research faculty at the Medical University of South Carolina-Charleston, he returned to India and set up Bharat Biotech International Limited, a multidimensional biotechnology company specializing in R&D, manufacturing and marketing of vaccines and biotherapeutics for human use. Today, Bharat Biotech is one of the leading innovative R&D Companies, with 45 global patents, of which five are for new molecules.
Ella’s scientific expertise is in gene knock-out and expression systems. As an entrepreneur with over two decades of experience in product development and manufacturing, he has recently ventured into other areas like veterinary vaccines (Biovet), food processing (Innova Agri Bio), functional foods (Century Biologicals), contract research services (RCC Labs) and developing biotechnology infrastructure (Konark Bio Park).
He has received several awards for his academic recognitions, including the Rotary Fellowship, and the National Research Service Award of the U.S. National Institutes of Health. He also has been honoured for his entrepreneurial skills with awards such as the J.R.D. TATA – Best Entrepreneur of the Year and Marico Innovation award received from the Prime Minister of India, among several others.
Ella is a member, adviror or chair of numerous committees that shape India’s science education, policy and international collaboration. These include the Five Year Plan for Biotechnology, Human Resource and Innovation; National Biotech Policy, High Technology Cooperation Groups; the National Task Force in Industrial Biotechnology, and the National Council of IPR. He has recently been nominated as a member of the Scientific Advisory Committee to the Prime Minister of India
John Holton, MS, is a successful health care entrepreneur with extensive experience in design, development, sales and support of health care information systems.
He founded and served as president and CEO of SCI, a cloud-based service connecting health systems to their community partners. Previously, he had founded AtWork Corporation, which became an industry leader in health care scheduling and management systems. Atwork twice made Inc. magazine’s list of the 500 fastest-growing private companies. He is currently chair and president of JWS Foundation, which provides students with need-based scholarships.
Holton earned his bachelor’s degree in History and a master’s in Industrial Engineering from UW-Madison. He received the College of Engineering’s Distinguished Service Award in 2000. He is also a member of the University of Wisconsin Foundation Board of Directors.
Ambassador John E. Lange, M.S., J.D., senior fellow for Global Health Diplomacy at the United Nations Foundation, serves as the foundation’s primary focal point for global health diplomacy activities and its wide-ranging work with the World Health Organization.
Lange worked from 2009-2013 at the Bill & Melinda Gates Foundation, where he engaged in high-level advocacy with international organizations and African governments. In 2012, he was the founding chair of the Polio Partners Group of the Global Polio Eradication Initiative and served as co-chair for four years.
Lange had a distinguished 28-year career in the Foreign Service at the U.S. Department of State, where he was a pioneer in the field of global health diplomacy. He served as the special representative on Avian and Pandemic Influenza; deputy U.S. Global AIDS coordinator at the inception of the President’s Emergency Plan for AIDS Relief; and U.S. Ambassador to Botswana (1999-2002), where HIV/AIDS was his signature issue. Lange led the U.S. Embassy in Dar es Salaam, Tanzania, as Chargé d’Affaires during the August 7, 1998, terrorist bombing. Earlier, he had tours of duty in Geneva, Lomé, Paris and Mexico City.
Lange co-chaired the U.S. Institute of Medicine committee that produced the 2014 report, Investing in Global Health Systems: Sustaining Gains, Transforming Lives. He is the author of a case study on pandemic influenza negotiations, has delivered numerous lectures on issues related to global health diplomacy, and writes a blog on global health in The Huffington Post. He has an M.S. degree from the National War College and J.D. and B.A. degrees from the University of Wisconsin-Madison.
Gary M. Tabor, VMD, MES, is an ecologist and wildlife veterinarian based in Bozeman, Montana. In 2007, he founded the Center for Large Landscape Conservation to help people and institutions make better land use decisions at the scale nature functions.
Tabor has worked on behalf of large landscape conservation internationally for over 35 years with ten years of experience in Africa, South America and Australia, and 12 years as a leader within the U.S. philanthropic community beginning. He has served with the Geraldine R. Dodge Foundation, the Henry P. Kendall Foundation, and, finally, as the Yellowstone to Yukon program director for the Wilburforce Foundation. His work in philanthropy also includes the design of international conservation trusts for USAID, and the World Bank. He also founded the Australia Environmental Grantmakers Association.
Tabor’s conservation achievements include the establishment of Kibale National Park in Uganda; establishment of the World Bank’s Mountain Gorilla Conservation Trust; co-founding the Yellowstone to Yukon Conservation Initiative; pioneering the field of Conservation Medicine and EcoHealth; co-founding Patagonia Company’s Freedom to Roam wildlife corridor campaign; co-founding the Practitioners’ Network for Large Landscape Conservation and the Roundtable of the Crown of the Continent – recent winner of the inaugural climate adaptation award by the US National Fish, Wildlife and Plants Climate Adaptation Strategy.
Tabor is a Henry Luce Scholar and recipient of the Australian American Fulbright Scholar award in Climate Change. He is Chair of the World Commission on Protected Areas’ new Connectivity Conservation Specialist Group.
Mary E. Wilson, M.D, FACP, FIDSA, FASTMH, is a clinical professor of Epidemiology and Biostatistics, University of California San Francisco and an adjunct professor of Global Health and Population, Harvard T.H. Chan School of Public Health. Her academic interests include the ecology of infections and emergence of microbial threats, travel medicine, and vaccines.
Wilson has served on Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP), the Academic Advisory Committee for the National Institute of Public Health in Mexico, and on five committees for the Institute of Medicine (National Academy of Medicine). She is a member of the Microbial Threats Forum at the National Academies. She is one of the medical editors for CDC’s Health Information for International Travel.
Wilson has worked in Haiti at the Albert Schweitzer Hospital and helped to develop the Harvard-Brazil Collaborative Course, taught in Brazil. She serves on several editorial boards and is an associate editor for NEJM Journal Watch Infectious Diseases. She is the author of A World Guide to Infections: Diseases, Distribution, Diagnosis (Oxford University Press); senior editor of Disease in Evolution: Global Changes and Emergence of Infectious Diseases (New York Academy of Sciences); and editor New and Emerging Infectious Diseases (Medical Clinics of North America). She served on the Board of Trustees for icddr,b (International Centre for Diarrheal Disease Research, Bangladesh) for 6 years.